Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1077 | 1148 | 1132 | 1313 | 1781 | 3511 |
Fund Return | 7.74% | 14.76% | 13.23% | 9.5% | 12.24% | 13.38% |
Place in category | 116 | 117 | 61 | 116 | 21 | 22 |
% in Category | 12 | 11 | 7 | 26 | 6 | 6 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S Horizon Global Technology Fund Ag | 21.59M | 19.52 | 12.31 | 18.91 | ||
S Horizon Global Technology Fund 1g | 2.83M | 19.98 | 13.29 | 19.95 | ||
S Horizon Global Technology Fund Hg | 6.78M | 13.85 | 12.16 | 19.04 | ||
Opportunities Fund I Inc | 41.76M | 7.80 | 8.83 | 9.20 | ||
Opportunities Fund P Acc | 496.23K | 7.92 | 9.13 | 9.50 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Wellington Global Health Care EquiG | 2.53B | 5.25 | 5.27 | 13.12 | ||
Global Health Care Fund W Acc GBP | 118.52M | -8.92 | 12.63 | 14.43 | ||
Adamant Medtech I GBP | 1.54B | 5.38 | 4.00 | 13.93 | ||
Pharmaceuticals Index Trust F Acc | 264.11K | 5.19 | 7.71 | 11.56 | ||
Pharmaceuticals Index Trust F Dist | 901.9Array | 5.21 | 7.68 | 11.55 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 6.66 | 865.82 | +0.09% | |
UnitedHealth | US91324P1021 | 5.99 | 496.22 | +0.25% | |
Novo Nordisk B | DK0062498333 | 4.82 | 982.0 | -0.65% | |
Merck&Co | US58933Y1055 | 3.57 | 131.84 | +0.27% | |
AstraZeneca | GB0009895292 | 3.57 | 12,376.0 | -1.78% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review